Not Signed In - Advancis Pharmaceutical Announces Positive Results For Amoxicillin PULSYS Phase III Trial
Sat, 12 Aug 2006 06:00 AM EST
... AdvancisPharmaceutical Corporation (Nasdaq: AVNC), a pharmaceutical company focusedon developing and commercializing novel anti-infective products, todayannounced that its Amoxicillin PULSYS Phase III clinical trial for thetreatment of adults and adolescents with pharyngitis/tonsillitis due [click link for full article] ...
Related Topics
- Clinical Trials
- Amoxicillin
- Antithrombin III
- Familial Dysautonomia
- Lansoprazole, Clarithromycin and Amoxicillin
- Amoxicillin and Clavulanate Potassium
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Tb
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - diabetic type
- Cranial mononeuropathy III - compression type
- Antithrombin
- Drug Information
- Osteogenesis imperfecta, type III
- HLA-B27
- Triple Screen
- TB Skin Test
- Albendazole
email this page
print this page
bookmark this page
feedback on this page
